QQ客服 官方微博 反馈留言

	Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis
	Liao, Weiting; Huang, Jiaxing; Wu, Qiuji; Zhu, Guiqi; Wang, Xinyuan; Wen, Feng; Zhang, Pengfei; Zhang, Nan; Li, Qiu
刊名	ORAL ONCOLOGY
	2019
卷号	93
关键词	Nasopharyngeal carcinoma Cost-ineffective Chemoradiotherapy Nedaplatin Markov model Economic evaluation
ISSN号	1368-8375
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3595936
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Liao, Weiting,Huang, Jiaxing,Wu, Qiuji,et al. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis[J]. ORAL ONCOLOGY,2019,93.
APA	Liao, Weiting.,Huang, Jiaxing.,Wu, Qiuji.,Zhu, Guiqi.,Wang, Xinyuan.,...&Li, Qiu.(2019).Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis.ORAL ONCOLOGY,93.
MLA	Liao, Weiting,et al."Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis".ORAL ONCOLOGY 93(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。